Chemoinformaics analysis of 2,5-DIMETHYLQUINOLINE
| Molecular Weight | 157.216 | nRot | 0 |
| Heavy Atom Molecular Weight | 146.128 | nRig | 11 |
| Exact Molecular Weight | 157.089 | nRing | 2 |
| Solubility: LogS | -2.422 | nHRing | 1 |
| Solubility: LogP | 2.879 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 11 |
| nHA | 1 | APOL | 26.8047 |
| nHD | 0 | BPOL | 12.1753 |
| QED | 0.573 |
| Synth | 1.624 |
| Natural Product Likeliness | -1.087 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.018 |
| Pgp-sub | 0.017 |
| HIA | 0.004 |
| CACO-2 | -4.614 |
| MDCK | 0.0000245 |
| BBB | 0.968 |
| PPB | 0.917491 |
| VDSS | 0.695 |
| FU | 0.0751289 |
| CYP1A2-inh | 0.981 |
| CYP1A2-sub | 0.95 |
| CYP2c19-inh | 0.404 |
| CYP2c19-sub | 0.724 |
| CYP2c9-inh | 0.095 |
| CYP2c9-sub | 0.67 |
| CYP2d6-inh | 0.76 |
| CYP2d6-sub | 0.924 |
| CYP3a4-inh | 0.318 |
| CYP3a4-sub | 0.434 |
| CL | 4.521 |
| T12 | 0.403 |
| hERG | 0.071 |
| Ames | 0.886 |
| ROA | 0.487 |
| SkinSen | 0.351 |
| Carcinogencity | 0.816 |
| EI | 0.99 |
| Respiratory | 0.946 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.674613 |